Zobair Younossi, MD

Articles by Zobair Younossi, MD

Changing Demographics Among Populations Prescribed HCV Treatment, 2013-2017

ByNaoky Tsai, MD,Bruce Bacon, MD,Michael Curry, MD,Steven L. Flamm, MD,Scott Milligan, PhD,Nicole Wick, AS,Zobair Younossi, MD,Nezam Afdhal, MD

July 12th 2019

From 2013 to 2017, the population of US patients prescribed treatment for chronic hepatitis C virus (HCV) changed, becoming predominantly treatment-naïve and having received care in nonacademic centers.

Treating Medicaid Patients With Hepatitis C: Clinical and Economic Impact

ByZobair Younossi, MD,Stuart C. Gordon, MD,Aijaz Ahmed, MD,Douglas Dieterich, MD,Sammy Saab, MD,Rachel Beckerman, PhD

February 16th 2017

Hepatitis C virus treatment is often restricted in Medicaid patients. This analysis evaluates the clinical and cost impacts of treating all Medicaid patients versus the current status quo.

Latest Updated Articles

Treating Medicaid Patients With Hepatitis C: Clinical and Economic Impact
Published: February 16th 2017 | Updated:
Changing Demographics Among Populations Prescribed HCV Treatment, 2013-2017
Published: July 12th 2019 | Updated:

Zobair Younossi, MD

Articles by Zobair Younossi, MD

Changing Demographics Among Populations Prescribed HCV Treatment, 2013-2017

Treating Medicaid Patients With Hepatitis C: Clinical and Economic Impact

Latest Updated Articles

Trending on AJMC

A "One-Two Punch" to Innovation? The Most Favored Nation Order and Broader US Drug Pricing Reform

Telemedicine Boosts Quality of Life, Inhaler Technique for Severe COPD

Bispecific Antibodies in Multiple Myeloma Are Moving From Clinical Trials to Community Practice

White House to Announce Second Drug Pricing Deal as AstraZeneca Joins TrumpRx

Smartphone App Reduces Depression in Adults With Intellectual Disabilities